Stock comparison

PFEvsZTS

Pfizer IncvsZoetis Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

PFE

Pfizer Inc

$26.67

+3.17%

Pharmaceuticals$155.1BNYSE

ZTS

Zoetis Inc

$116.06

-2.19%

Pharmaceuticals$48.8BNYSE

60-day price, rebased to 100

PFE +3.13% · ZTS -4.81%

Round-by-round

PFE 3·ZTS 2· 1tie

EdgePFE

Valuation upside

-18.10% vs -36.20% to DCF fair value

EdgeZTS

Balance-sheet strength

Altman Z 2.15 vs 5.39

Tie

Fundamental quality

Piotroski 6.00 vs 6.00 (of 9)

EdgeZTS

Growth + margins

Rule-of-40 12.90 vs 26.40

EdgePFE

60-day momentum

+3.13% vs -4.81% price return

EdgePFE

Market-cap liquidity

$155.1B vs $48.8B

Verdict

Across6categories,PFEtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onPFEorZTS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.